About Tessera Therapeutics
We are pioneering Gene Writing (TM) beyond its current limitations.
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Somerville, MA
- Company type
- Privately Held
Tessera Therapeutics is a biotechnology company pioneering a new approach to genome engineering through the development of its Gene Writing™ and delivery platforms, with the aim to unlock broad new therapeutic frontiers.
Our mission is to cure disease by writing in the code of life. We believe our Gene Writing™ and delivery platforms will enable transformative genetic medicines to treat monogenic diseases, cancer and potentially autoimmune and other diseases.
Discover your future at Tessera.
Company locations
Somerville, MA 02143, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Biopharma
- Biotechnology
- Life Science
- Genetics
- Therapeutics
On LinkedIn
- Followers
- 45,485
- People linked to this company
- 200
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
773,055,224 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.